Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BA.2.24EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BA.2.24EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BA.2.24ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.24ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.3.11EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.2.3.11EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.3.11ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BA.2.3.11ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BA.2.3.11EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BA.2.3.11EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BA.2.3.11ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.3.11ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.3.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.2.3.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-463.749South Korea
BA.2.3.2ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BA.2.3.2ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-4212.07Germany
BA.2.3.2EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BA.2.3.2EHuang-EGCAGCAGTACGCACACAATC20552637626357R-5161.21China
BA.2.3.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.3.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.06China
BA.2.85EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.2.85EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.85ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BA.2.85ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BA.2.85EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BF.7.13.2ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BF.7.13.2ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BF.7.13.2EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BF.7.13.2EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BF.7.13.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BF.7.13.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BF.37EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BF.37EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.37ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BF.37ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BF.37EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BF.37EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BF.37ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BF.37ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CK.3EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
CK.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CK.3ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
CK.3ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
CK.3EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
CK.3EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
CK.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
CK.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CM.5EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
CM.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CM.5ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used